Weber C.E., Kothari A.N., Wai P.Y., Li N.Y., Driver J., Zapf M.A.C.,Franzen C.A., Gupta G.N., Osipo C., Zlobin A., Syn W.K., Zhang J.,Kuo P.C., Mi Z. Osteopontin mediates an MZF1–TGF-β1-dependenttransformation of mesenchymal stem cells into cancer-associatedfibroblastsin breast cancer. The gene discussed is SPP1; the disease is breast carcinoma.